-
2 months ago | 
outsourcedpharma.com | Sabyasachi Ghosh |Louis Garguilo
By Sabyasachi Ghosh, Future Market Insights
As consumer preferences for natural and organic products rise, businesses in the pharma and nutraceuticals industries are increasingly shifting to plant-based active pharmaceutical ingredients (APIs).
Post-pandemic, significant changes have reshaped how companies manufacture medications. With an increasing number of people seeking natural and organic medicines, the demand for plant-derived APIs has reached an all-time high.
-
Feb 26, 2024 | 
pharmiweb.com | Sabyasachi Ghosh
Disclaimer: You are now leaving PharmiWeb.com website and are going to a website that is not operated by us. We are not responsible for the content or availability of linked sites.
ABOUT THIRD PARTY LINKS ON OUR SITE
PharmiWeb.com offers links to other third party websites that may be of interest to our website visitors. The links provided in our website are provided solely for your convenience and may assist you in locating other useful information on the Internet.
-
Dec 22, 2023 | 
outsourcedpharma.com | Sabyasachi Ghosh |David Lyon |Molly Adam |Ken Ball |Louis Garguilo
Enteric gel capsules ensure medications are released in the small intestine rather than the stomach, enhancing drug efficacy while minimizing gastrointestinal side effects, and making them a preferred choice for patients. This article examines new market research insights.
-
Nov 7, 2023 | 
pharmaceuticalonline.com | Sabyasachi Ghosh
Get more pharma manufacturing insight with our FREE newsletter
Guest Column
| November 7, 2023
By Sabyasachi Ghosh, Future Market Insights
The enteric gel capsules market has been experiencing remarkable growth in recent years, thanks to the increasing demand for advanced drug delivery systems.
-
Nov 2, 2023 | 
outsourcedpharma.com | Louis Garguilo |Sabyasachi Ghosh |Laura McWhinney |William Powers
Interested in bringing your monoclonal antibody from transfection to GMP drug substance in nine months? Join us for a panel discussion to explore our Accelerated mAb Development Program. Meet our experts, who have developed our phase-appropriate and cost-effective program, which is scalable and integrates strategies for risk mitigation. Watch now.
-
Oct 17, 2023 | 
drugdiscoveryonline.com | Sabyasachi Ghosh |Dan Bowles |Mike Johnson |Brian Swierenga
The U.S. is at the forefront of the AI-based research trend surge to elevate the understanding of human physiology, testing potential therapies, and identifying disease mechanisms. Let's examine the five most promising innovative advancements in animal models, as well as key considerations for those working in the field.
-
Sep 29, 2023 | 
bioprocessonline.com | Sabyasachi Ghosh
By Sabyasachi Ghosh, Future Market Insights
Industry momentum is trending in favor of single-use bioreactors as a plurality of biopharmaceutical companies are opting for the disposable version of bioreactors, according to our new market research. This change in direction motion is largely underpinned by the fact that disposable or single-use bioreactors employ pre-sterilized bioprocess bags. Thus, they curtail the period of sterilization and any associated additional costs.
-
Aug 16, 2023 | 
drugdiscoveryonline.com | Sabyasachi Ghosh
By Sabyasachi Ghosh, Future Market Insights
Animal models have long been instrumental in advancing biomedical research and facilitating drug development. The U.S. animal model market is at the forefront of the artificial intelligence-based research trend surge to elevate the understanding of human physiology, testing potential therapies, and identifying disease mechanisms.
One particularly ground-breaking trend in the U.S. animal model industry is the emergence of organoid intelligence.
-
Aug 2, 2023 | 
chronicles24.com | Sabyasachi Ghosh
Proteinase K is a million dollar market accounting for a small portion in reagents and enzymes. Proteinase K is mainly used in contract research organisations, biotechnology companies, academic institutes, and diagnostics laboratories. In terms of revenue, the global Proteinase K market is expected to reach US$ 33.4 Mn by the end of 2026, witnessing a CAGR of [...]
-
Jul 27, 2023 | 
chronicles24.com | Sabyasachi Ghosh
In 2019, the global demand for late-stage chronic kidney disease therapeutics was estimated to be around US$4.7 billion. However, due to the rising prevalence of chronic kidney disease around the world, the global late stage kidney disease therapeutics market is expected to surpass US$ 11.1 billion in 2027 and grow at a robust CAGR of around [...]
